Korean J Anesthesiol.  1976 Dec;9(2):291-298.

A Clinical Comparison of Pancuronium and Succinylcho! ine for Cesarean Section Anesthesia

Affiliations
  • 1Department of Anesthesiology, Presbyterian Medical Center, Jeonju, Korea.

Abstract

In this study, we adopted two different general anesthetic techniques for Cesarean section. Patients were randomly assigned to two groups; Group I ; 51 patients, thiopental-succinylcholine-nitrous oxide-oxygen supplemented with ether or halothans anesthesia. Group II 67 patients, pancuronium-thiopental-nitrous oxide-oxygen supplemented with ether or halothane anesthesia. Group I (Succinylcholine group): 51cases were induced for anesthesia with 150~250mg of thiopental and intubated with 1mg/ kg of succinylcholine followed by 100% oxygen with controlled ventilation. After delivering the fetus, anesthesia was maintained with nitrous oxide-oxygen-ether or halothane throughout- the procedure. Group III (Pancuronium group); Anesthesia was performed with150~250mg of thiopental, 0. 08mg/kg of pancuronium with endotracheal intubation for 67 patients. After delivery, nitrous oxide with oxygen and supplemental ether or halothane were given, if necessary. It was concluded that incidence of hypotension was less in the pancuronium group, and no evidence of fetal effects was seen. And there is no clinical evidence of significant placental transfer of pancuronium and that this is a safe and efficacious agent for incorporation into the nitrous oxide-relaxant anesthetic technique for Cesarean section. No clear superiority of succinylcholine over pancuronium was demonstrated in this study.


MeSH Terms

Anesthesia*
Cesarean Section*
Ether
Female
Fetus
Halothane
Humans
Hypotension
Incidence
Intubation, Intratracheal
Nitrous Oxide
Oxygen
Pancuronium*
Pregnancy
Succinylcholine
Thiopental
Ventilation
Ether
Halothane
Nitrous Oxide
Oxygen
Pancuronium
Succinylcholine
Thiopental
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr